Insilico Medicine uses AI to discover novel SIK2 inhibitors

Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.

Sports betting is coming to Missouri. A fund to help prevent problem gambling will follow.

Listen as senior producer Zach Dyer reports on the public health concerns over online sports betting and a fund in Missouri that might help with

January 29, 2025

Counter-Marketing Messages Reduced Intent to Drink Sugary Beverages

SAN ANTONIO — While both health education-focused messaging and a counter-marketing messaging approach reduced adults’ intent to consume sugary drinks, the former invoked more perceived

November 7, 2024

Siemens Healthineers Adopts NVIDIA’s MONAI Deploy for Faster AI Deployment

What You Should Know: – Siemens Healthineers, a global leader in medical technology, has adopted NVIDIA MONAI Deploy to accelerate integrating AI workflows into its

December 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.